Industry news focusing on the people and organizations who work in the clinical trials profession.
William B. Gerraughty, Jr.
Continuing to serve as Sparta System's (Holmdel, NJ) Chief Financial Officer, William B. Gerraughty, Jr., has also been promoted to Chief Operating Officer where in addition to managing the company's legal and human resource departments he will also oversee the day-to-day operations, provide planning and resource allocation, and advise the CEO and management team on key planning issues and business decisions.
A new position at Catalent Pharma Solutions (Somerset, NJ), Director of Environmental Health and Safety for Printed Components Business, will be filled by Robert Romance.
Working in the regulatory affairs sector in areas such as wound care, vaccine, and pharmaceutical manufacturing, Elizabeth Vincent will use her past experience in her new position as Regulatory Affairs Manager for Trac Services (Camborne, England).
Twenty five years of experience in clinical research and business development has landed Art Ziegler a job as Vice President of Business Development for Prologue Research (Columbus, OH) where he will develop and implement marketing and sales initiatives, and push for the company's services within oncology research and in other business areas.
Woodley Equipment (Lancashire, UK) has made two new additions to its team with the appointment of David Wood as Medical Electronics Manager and Joanne Platt as Customer Service Representative.
With a background of 25 years in international financial experience and 10 of those years being spent in the biotechnology industry, Hervé Duchesne de Lamotte was chosen to become ExonHit Therapeutic's (Paris, France) new Chief Financial Officer.
Frontage (Exton, PA) has made several additions to its team, including the appointment of Samir Ghodbane, PhD, to the General Manager of CMC services and CTM manufacturing; Daniel Tang, PhD, as Vice President of DMPK and bioassay for China operations; and Ron Connolly as Senior Vice President of business development.
Filling the role of Vice President of Strategic Alliances for Kforce (Tampa, FL) due to a promotion, Mark Lanfear will become responsible for leading client relationship management and development efforts, as well as forging the partnership strategy for multinational expansion.
After serving as senior vice president of sales and marketing for Brecon Pharmaceutical's (Valley Forge, PA) AmerisourceBergen Packaging Group sister company, Anderson Packaging (Rockford, IL), Peter Belden will now become Brecon's new Managing Director.
Vetter executives, along with Illinois Biotechnology Industry Organization and Economic Development executives, dedicate Vetter's new facility in suburban Chicago.
Extending on a previous agreement, ICON (Dublin, Ireland) will continue to manage the clinical data management outside the United States for Eli Lilly (Indianapolis, IN).
Four new task orders have been assigned to C-TASC (Baltimore, MD) by the FDA (Silver Spring, MD), requesting statistical analysis support and data conversion services for clinical trials.
An alliance with AstraZeneca (Wilmington, DE) will assume Quintiles (Research Triangle Park, NC) with the responsibility of delivering the company's clinical pharmacology studies worldwide and across a range of therapeutic areas.
A multiyear agreement with Phase Forward (Waltham, MA) will allow PharmaNet (Princeton, NJ) to offer the company's InForm electronic data capture solution to its customers worldwide.
A new, extended contract between Medidata Solutions (New York, NY) and Shire plc (Dublin, Ireland) will enable the latter to use Medidata Grants Manager and CRO Contractor and to implement three analysis modules to further enhance its processes.
Adding four more years to a collaboration that began in 2004, Evotec AG (Hamburg, Germany) and Boehringer Ingelheim (Ingelheim, Germany) will continue to work together in the areas of CNS, inflammation, cardiometabolic, and respiratory diseases and because of the success in those areas will add oncology targets.
To develop six potential oncology products in Eisai's (Toyko, Japan) R&D pipeline, Quintiles (Research Triangle Park, NC) will conduct Phase II proof-of-concept studies for 11 solid tumor indications.
To provide sponsors with a global network, particularly strengthening services in India, Europe, and Japan, Tokyo CRO (Tokyo, Japan) and Ecron Acunova (Bangalore, India) have formed a strategic alliance.
Executive Vice President and Chief Information Officer of Quintiles (Research Triangle Park, NC), William Deam, has been named to CIO Magazine's CIO Hall of Fame.
At the 2009 Mass Technology Leadership Awards held in Boston, MA, the Mass Technology Leadership Council named Phase Forward (Waltham, MA) the Private Sector Company of the Year.
Based on its percentage of growth and profitability over a three year period, Novella Clinical (Research Triangle Park, NC) was ranked number two at the annual Fast 50 awards, which recognize the 50 fastest growing private companies in the Triangle region of North Carolina.
BioAlliance Pharma (Paris, France) has won first prize in Deloitte's Technology Fast 50 of 2009, which ranks France's fastest growing technology companies.
Meeting the qualifying criteria of increasing revenues for the past three years as an independent, privately held, for-profit company; being headquartered in the Cincinnati regions; and having a three-year operating history, Camargo (Cincinnati, OH) walked away as one of Cincinnati's 55 fastest-growing private companies for 2009.
The Swedish business magazine, Veckans Affärer, has dubbed TFS Trial Form Support International (Lund, Sweden) as one of the 50 best working places in Sweden.
Expanding its functional sourcing resources into Eastern Europe, Premier Research Group (Philadelphia, PA) intends on this presence to provide more cost savings for its clients.
Initiated as Pivotal Laboratories, ACM Global Central Laboratory (York, England) is celebrating 10 years of providing central lab services throughout Europe.
Vitalograph (Buckingham, England) has successfully passed its first routine inspection by The Medicines and Healthcare products Regulatory Agency (MHRA), with a report of zero critical findings, zero major findings, and only a handful of observations.
Now with advanced nuclear imaging function for cardiology clinical trials, Perceptive Informatics (Boston, MA) has expanded its medical imaging capabilities.
Biocair (Cambridge, UK) has obtained a new Chinese Business License and is expanding its operations into China.
Managing to avoid any drastic changes, CTI Clinical Trial and Consulting Services (Cincinnati, OH) has acquired CRS Clinical Research Services and CRS—Staff Leasing Services (Kiel, Germany) and will incorporate all of the company's employees as well as maintain CRS' headquarters.
Helping to strengthen PPD's (Wilmington, NC) presence in the Asia Pacific market is its acquisition of Excel PharmaStudies, a large contract research organization located in China. PPD has also acquired BioDuro, who has a presence in Beijing, which will help to expand the company into China.
An investment of €2.7 million by Quay Pharmaceuticals (Bromborough, England) is going to provide the company with a new headquarters and manufacturing facility located in North Wales, where it intends to create 54 new jobs with support from the Welsh Assembly Government.
The opening of a new office in Moscow, Russia, this past October will help to strengthen the CRO Ecron Acunova's (Bangalore, India) presence in Eastern Europe.
Vetter (Ravensburg, Germany) has chosen Chicago as the location of its new facility based on its thriving biopharmaceutical region, established infrastructure, and talent pool of 70,000 to 80,000 professionals.